Pelthos Therapeutics Inc. Share Price
NASDAQ: PTHS
Live Pelthos Therapeutics Inc. Share Price Chart
O H L
Pelthos Therapeutics Inc. Performance Overview
Days Range
▼
$21.97Low
$22.65High
Markets Today
| Previous Close | $22.38 |
|---|---|
| Open | $21.97 |
| Volume | 17,296 |
| Day's Range | $21.97 - $22.65 |
| 52W Range | NA |
| Market Cap | $74.35 M |
Historical Performance
| 1M Returns | -14.29 |
|---|---|
| 3M Returns | -22.83 |
| 6M Returns | -7.06 |
| 1Y Returns | -32.81 |
| 5Y Returns | NA |
| 10Y Returns | NA |
Pelthos Therapeutics Inc. Fundamentals
| Market Cap | $74.35 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $16.80 M |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-30.14 M |
| Profit Margin | -257.93 |
| Market Cap | $74.35 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $16.80 M |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-30.14 M |
| Profit Margin | -257.93 |
Pelthos Therapeutics Inc. Profit & Loss
Quarterly
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Total Revenue + | $7.41 M | $9.39 M | $10.91 M | $15.60 M |
| Gross Profit + | $5.09 M | $7.72 M | $9.23 M | $11.99 M |
| Operating Income | -$15.36 M | -$12.00 M | -$13.09 M | -$17.32 M |
| EBITDA | -$14.29 M | -$10.79 M | -$11.59 M | -$16.00 M |
| Interest Expense | -$1.35 M | -$1.31 M | -$2.35 M | -$2.39 M |
| Depreciation | $1.07 M | $1.22 M | $1.50 M | $1.32 M |
| Income Before Tax | -$16.70 M | -$28.59 M | -$25.07 M | -$23.42 M |
| Income Tax Expense | -$465.00 K | -$6.92 M | $0 | $0 |
| Net Income + | -$16.24 M | -$21.66 M | -$25.07 M | -$23.42 M |
| Net Profit Margin | -219.25% | -230.74% | -229.9% | -150.08% |
Pelthos Therapeutics Inc. Financials Balance Sheet In USD
Quarterly
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Share Capital | $0 | $0 | $0 | $0 |
| Reserve & Surplus | -$43.13 M | -$64.79 M | -$87.68 M | -$111.21 M |
| Non-Current Liabilities | $43.41 M | $65.52 M | $101.11 M | $106.90 M |
| Current Liabilities | $24.77 M | $25.99 M | $25.00 M | $31.96 M |
| Total Liabilities | $68.18 M | $91.52 M | $126.11 M | $138.86 M |
| Fixed Assets | $42.70 M | $49.06 M | $47.75 M | $46.28 M |
| Current Assets | $49.76 M | $53.41 M | $69.80 M | $63.36 M |
| Total Assets | $126.43 M | $130.40 M | $145.38 M | $137.36 M |
Pelthos Therapeutics Inc. Cash Flow
Quarterly
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Net Income | -$16.24 M | -$21.66 M | -$25.07 M | -$23.42 M |
| Operating Cash Flow | -$15.26 M | -$6.25 M | -$13.13 M | -$7.66 M |
| Investing Cash Flow | $2.76 M | -$8.00 M | -$194.00 K | -$2.00 K |
| Financing Cash Flow | $26.69 M | $18.02 M | $27.52 M | $0 |
| Change in Cash | $14.19 M | $3.77 M | $14.20 M | -$7.67 M |
Pelthos Therapeutics Inc. Return Calculator
The Pelthos Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Pelthos Therapeutics Inc.
Pelthos Therapeutics Inc is a biopharmaceutical company committed to commercializing safe and efficacious therapeutic products to help patients with unmet treatment burdens. The Company currently has three U.S. Food and Drug Administration (FDA) approved products in its commercial portfolio, in various stages of commercialization, including ZELSUVMITM, XEPI, and XEGLYZE. The company operates in two reporting segments: the sale, promotion, and commercialization of approved commercial products, the Commercial Operations segment, and research and development activities related to developing a novel and proprietary class of NaV blockers that target the body's peripheral nervous system; and supportive activities to expand the NITRICIL nitric oxide-based technology.
Popular Stocks
FAQs
What is the share price of Pelthos Therapeutics Inc. today?
Pelthos Therapeutics Inc. (PTHS) share price as of September 18, 2026 is $21.70. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Pelthos Therapeutics Inc.?
Yes, Indian Investors can invest in the Pelthos Therapeutics Inc. (PTHS) Share by opening an international trading account with Angel One.
How can I purchase Pelthos Therapeutics Inc. shares in India?
Purchasing Pelthos Therapeutics Inc. (PTHS) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Pelthos Therapeutics Inc. (PTHS) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Pelthos Therapeutics Inc.?
Yes, you can purchase fractional shares of Pelthos Therapeutics Inc. (PTHS) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Pelthos Therapeutics Inc.?
The market capitalization of Pelthos Therapeutics Inc. on September 18, 2026, is $74.35 M.
In which sector Pelthos Therapeutics Inc. belongs?
Pelthos Therapeutics Inc. operates in the null sector, specifically in the null industry.
What documents are required to invest in Pelthos Therapeutics Inc. stocks?
In order to invest in Pelthos Therapeutics Inc. (PTHS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
